Functional and Anatomical Outcomes Following Intravitreal Bevacizumab in Treatment-Naïve Centre-Involving Diabetic Macular Edema: A 3-Month Prospective Evaluation. J. Heal. Rehab. Sci. 2025, 4 (2), 1-10. https://doi.org/10.33700/jhrs.4.2.172.